Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasting, Serplulimab, and CAPEOX for Locally Advanced Rectal Cancer
NCT07779694Phase 2Not yet recruiting
- Sponsor
- Zhejiang University
- Start
- Oct 2026
- Primary completion
- Dec 2028
01
Overview
A Phase 2 trial of serplulimab in rectal cancer, sponsored by Zhejiang University. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
serplulimab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT07779694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07779694.